123 related articles for article (PubMed ID: 16227401)
1. Isothiazolones as inhibitors of PCAF and p300 histone acetyltransferase activity.
Stimson L; Rowlands MG; Newbatt YM; Smith NF; Raynaud FI; Rogers P; Bavetsias V; Gorsuch S; Jarman M; Bannister A; Kouzarides T; McDonald E; Workman P; Aherne GW
Mol Cancer Ther; 2005 Oct; 4(10):1521-32. PubMed ID: 16227401
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of a Tip60 specific inhibitor, NU9056, in prostate cancer.
Coffey K; Blackburn TJ; Cook S; Golding BT; Griffin RJ; Hardcastle IR; Hewitt L; Huberman K; McNeill HV; Newell DR; Roche C; Ryan-Munden CA; Watson A; Robson CN
PLoS One; 2012; 7(10):e45539. PubMed ID: 23056207
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of histone acetyltransferase by glycosaminoglycans.
Buczek-Thomas JA; Hsia E; Rich CB; Foster JA; Nugent MA
J Cell Biochem; 2008 Sep; 105(1):108-20. PubMed ID: 18459114
[TBL] [Abstract][Full Text] [Related]
4. Spatial memory consolidation is associated with induction of several lysine-acetyltransferase (histone acetyltransferase) expression levels and H2B/H4 acetylation-dependent transcriptional events in the rat hippocampus.
Bousiges O; Vasconcelos AP; Neidl R; Cosquer B; Herbeaux K; Panteleeva I; Loeffler JP; Cassel JC; Boutillier AL
Neuropsychopharmacology; 2010 Dec; 35(13):2521-37. PubMed ID: 20811339
[TBL] [Abstract][Full Text] [Related]
5. Novel berberine derivatives as p300 histone acetyltransferase inhibitors in combination treatment for breast cancer.
Lai R; Lin Z; Yang C; Hai L; Yang Z; Guo L; Nie R; Wu Y
Eur J Med Chem; 2024 Feb; 266():116116. PubMed ID: 38215590
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of lysine acetyltransferase KAT3B/p300 activity by a naturally occurring hydroxynaphthoquinone, plumbagin.
Ravindra KC; Selvi BR; Arif M; Reddy BA; Thanuja GR; Agrawal S; Pradhan SK; Nagashayana N; Dasgupta D; Kundu TK
J Biol Chem; 2009 Sep; 284(36):24453-64. PubMed ID: 19570987
[TBL] [Abstract][Full Text] [Related]
7. Discovery of berberine analogs as potent and highly selective p300/CBP HAT inhibitors.
Zhong X; Deng H; Long M; Yin H; Zhong Q; Zheng S; Gong T; He L; Wang G; Sun Q
Bioorg Chem; 2023 Sep; 138():106597. PubMed ID: 37245245
[TBL] [Abstract][Full Text] [Related]
8. Effective Quenchers Are Required to Eliminate the Interference of Substrate: Cofactor Binding in the HAT Scintillation Proximity Assay.
Ngo L; Wu J; Yang C; Zheng YG
Assay Drug Dev Technol; 2015 May; 13(4):210-20. PubMed ID: 26065557
[TBL] [Abstract][Full Text] [Related]
9. Acetyltransferases (HATs) as targets for neurological therapeutics.
Schneider A; Chatterjee S; Bousiges O; Selvi BR; Swaminathan A; Cassel R; Blanc F; Kundu TK; Boutillier AL
Neurotherapeutics; 2013 Oct; 10(4):568-88. PubMed ID: 24006237
[TBL] [Abstract][Full Text] [Related]
10. TAZ2 truncation confers overactivation of p300 and cellular vulnerability to HDAC inhibition.
Xu L; Xuan H; He W; Zhang L; Huang M; Li K; Wen H; Xu H; Shi X
Nat Commun; 2023 Sep; 14(1):5362. PubMed ID: 37660055
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of anticancer activity of CBP/p300 inhibitors - Features of their classes, intracellular targets and future perspectives of their application in cancer treatment.
Strachowska M; Robaszkiewicz A
Pharmacol Ther; 2024 May; 257():108636. PubMed ID: 38521246
[TBL] [Abstract][Full Text] [Related]
12. Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo.
Gajer JM; Furdas SD; Gründer A; Gothwal M; Heinicke U; Keller K; Colland F; Fulda S; Pahl HL; Fichtner I; Sippl W; Jung M
Oncogenesis; 2015 Feb; 4(2):e137. PubMed ID: 25664930
[TBL] [Abstract][Full Text] [Related]
13. Protein lysine acetyltransferase CBP/p300: A promising target for small molecules in cancer treatment.
Gou P; Zhang W
Biomed Pharmacother; 2024 Feb; 171():116130. PubMed ID: 38215693
[TBL] [Abstract][Full Text] [Related]
14. Lysosome-dependent p300/FOXP3 degradation and limits Treg cell functions and enhances targeted therapy against cancers.
Du T; Nagai Y; Xiao Y; Greene MI; Zhang H
Exp Mol Pathol; 2013 Aug; 95(1):38-45. PubMed ID: 23644046
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel nucleoside derivatives as selective lysine acetyltransferase p300 inhibitors for cancer therapy.
Dai Q; Yuan Z; Sun Q; Ao Z; He B; Jiang Y
Bioorg Med Chem Lett; 2024 May; 104():129742. PubMed ID: 38604299
[TBL] [Abstract][Full Text] [Related]
16. Small molecule inhibitors of histone acetyltransferase Tip60.
Wu J; Wang J; Li M; Yang Y; Wang B; Zheng YG
Bioorg Chem; 2011 Feb; 39(1):53-8. PubMed ID: 21186043
[TBL] [Abstract][Full Text] [Related]
17. Acetyl-CoA biosynthesis drives resistance to histone acetyltransferase inhibition.
Bishop TR; Subramanian C; Bilotta EM; Garnar-Wortzel L; Ramos AR; Zhang Y; Asiaban JN; Ott CJ; Rock CO; Erb MA
Nat Chem Biol; 2023 Oct; 19(10):1215-1222. PubMed ID: 37127754
[TBL] [Abstract][Full Text] [Related]
18. Acetyl-Click Screening Platform Identifies Small-Molecule Inhibitors of Histone Acetyltransferase 1 (HAT1).
Gaddameedi JD; Chou T; Geller BS; Rangarajan A; Swaminathan TA; Dixon D; Long K; Golder CJ; Vuong VA; Banuelos S; Greenhouse R; Snyder MP; Lipchik AM; Gruber JJ
J Med Chem; 2023 Apr; 66(8):5774-5801. PubMed ID: 37027002
[TBL] [Abstract][Full Text] [Related]
19. An Acetyl-Click Chemistry Assay to Measure Histone Acetyltransferase 1 Acetylation.
Rajkumar S; Dixon D; Lipchik AM; Gruber JJ
J Vis Exp; 2024 Jan; (203):. PubMed ID: 38345235
[TBL] [Abstract][Full Text] [Related]
20. Small-molecule inhibitors of the protein methyltransferase SET7/9 identified in a high-throughput screen.
Francis NJ; Rowlands M; Workman P; Jones K; Aherne W
J Biomol Screen; 2012 Sep; 17(8):1102-9. PubMed ID: 22772057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
